BigHat Biosciences

BigHat Biosciences is developing an AI-guided protein therapeutic design platform that integrates high-speed antibody characterization laboratories with machine learning technology to design molecules with more complex functionalities and better biophysical properties. The company is leveraging these design capabilities to develop a new generation of safer and more effective treatments for patients suffering from today's most challenging diseases.